Rhabdomyosarcoma Treatment in Tel Aviv | TOP 10+ Clinics ▷ Prices 2026

How it works

We've transformed the clinic search process, making it simple, fast, and personal.

Answer a few questionsFill out a short form to tell us about your condition and medical needs.

Get personalized offers3 clinics, handpicked based on your answers, provide tailored treatment plans and quotes.

Choose the best optionCompare offers and choose the clinic that suits you best.

You can also browse all 2 clinics below.

820К+ patients have got assistance since 2014

50 countries

1,500 clinics

6K+ reviews

3K+ qualified doctors

How Much Does Rhabdomyosarcoma Treatment Cost in Tel Aviv?

The price is provided on request

	Israel	Turkey	Austria
Chemotherapy for breast cancer	from $22,500	from $1,200	from $15,000

Data verified by Bookimed as of March 2026, based on patient requests and official quotes from 55 clinics worldwide. Median costs are based on real invoices (2025–2026) and updated monthly. Actual prices may vary.

Best Rhabdomyosarcoma Hospitals in Tel Aviv: 2 Verified Options and Prices

The Bookimed clinic ranking is based on data science algorithms, providing a trusted, transparent, and objective comparison. It takes into account patient demand, review scores (both positive and negative), the frequency of updates to treatment options and prices, response speed, and clinic certifications.

Sourasky Medical Center (Ichilov)

Israel, Tel Aviv

Roth Jonathan

30 years of experience

Clinic is certified :

Dr. Roth Jonathan is the lead specialist for this listing. Diagnostics at the JCI-accredited Sourasky Medical Center start from around $1,400 for a pediatric oncology consultation. A comprehensive rhabdomyosarcoma treatment program may cost around $50,000 and includes consultation, imaging, blood tests, and hospitalization. The center offers Foundation One CDx genetic testing, 3D navigation surgery, and immunotherapy based on genetic results.

diagnostics
PET/CT	$1,600 - $1,680

Assuta Medical Center

Israel, Tel Aviv

Riad Hadad

Clinic is certified :

Assuta Medical Center specializes in oncology with a dedicated focus on Rhabdomyosarcoma treatment. Dr. Riad Hadad, a leading oncologist with training at the University of Toronto, heads the department for liver, pancreas, and gallbladder treatment. He is a member of the European Society of Surgical Oncology and the Israeli Society of Surgical Oncology, with 60+ scientific publications.

diagnostics
CT (computer tomography)	$510
PET/CT	$1,680

Get a Medical Assessment for Rhabdomyosarcoma in Israel: Consult with Experienced Doctors Now

View all Doctors

Ofer Merimsky

41 years of experience

Specializing in soft tissue and bone oncology for over _doctor_28_years_, Prof. Merimsky heads the sarcoma unit at Sourasky Medical Center.

Fellowship-trained in sarcoma at Institut Gustave Roussy, Paris
ESMO faculty member for soft tissue and bone sarcomas
Led Tel-Aviv University's oncology department
Published extensive research on bone and soft tissue tumors

Ronit El Hasid

38 years of experience

Dr. El Hasid has performed over 300 bone marrow and cord blood transplants for children as head of pediatric oncology at Dana Dwek Hospital.

Specializes in transplant-based treatments for pediatric cancers
Published 50+ medical papers and presented 40 conference reports
Member of the American Association for Hematology and Israeli pediatric oncology society
Trained internationally at City of Hope Hospital in Los Angeles

Dror Levin

41 years of experience

Dr. Dror Levin is a senior pediatric oncologist in Israel, specializing in childhood sarcomas at the Sourasky Medical Center.

He studied pediatric sarcoma oncology at the world-leading Rizzoli Orthopaedic Institute in Bologna.
As director of pediatric hemato-oncology at Sourasky, he coordinates sarcoma treatment for children.
He is a member of the Israel Society of Pediatric Hemato-Oncology (ISPHO).
His expertise includes pediatric hematology, oncology, and specialized bone cancer care.

Mordechai Gutman

Dr. Gutman is a dedicated oncosurgeon specializing in complex cancer cases at Assuta Medical Center.

Specializes in surgical oncology with a focus on rare cancers
Works at Assuta Medical Center, a leading oncology facility
Experienced in managing challenging tumor cases

Share this content

Twitter X Linkedin Facebook WhatsApp Email

Get link

Updated: 05/27/2022

Authored by

Head of Content Marketing Team

A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.

Reviewed by Bookimed Medical Advisor

Medical Editor & Data Scientist

General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.

This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

All medical content on this page is prepared by authors with specialized medical education and reviewed by certified physicians in the relevant field. Medical review by Fahad Mawlood, Medical Editor & Data Scientist.

Last updated: February 18, 2026.

Statistics: Figures are based on Bookimed’s internal database March 2026, which includes analysis of 12,450 patient requests across 2 accredited clinics in Israel.
Pricing: Cost information is provided directly by Bookimed’s partner clinics and updated regularly to reflect current 2026 market conditions. Actual expenses may differ depending on case complexity, surgeon expertise, and clinic location.
Clinical Data: Treatment outcomes and patient satisfaction figures are collected from Bookimed’s verified clinic database and supported by data from peer-reviewed medical sources such as PubMed, The Lancet, JAMA, and NEJM (2023–2026).

All data is provided for general informational purposes and may not represent individual results or experiences.